Getting bioinformatics staffing right is the part of building a sequencing program that most directly determines whether completed runs actually turn into results, and it is the part most often left to chance. The tempting non-decision is to assume that a capable bench scientist will absorb the data analysis alongside their existing work, which looks free because it adds nothing to the payroll. It is not free. The cost simply moves off the salary line and reappears as delay: analysis that competes with bench duties for attention, results that arrive late or not at all, and a growing backlog of unanalyzed runs that represent money already spent and value not yet delivered. The most expensive staffing model is the one that never appears in the budget.
This guide covers the staffing decision honestly: what the analysis roles actually do, the three models for providing the capability, embedded, shared, and contracted, what bioinformatics staff cost with sources named, whether to train bench staff or hire specialists, and how to keep an analysis backlog from forming. It is about the staffing decision, not about how the analysis itself works or how to build a pipeline, which is a separate subject. The choice of analysis software these staff will use is covered in Choosing Genomic Data Analysis Software.
Key Takeaways
|
Roles and What Each Actually Does
Bioinformatics is not a single job, and understanding the distinct roles is the basis for staffing the function correctly rather than hiring a title and hoping it covers the need. In practice the work spans a spectrum from running established analyses to building new ones. At one end is the analyst who runs existing, validated pipelines on incoming data, interprets the output, and handles routine quality control, the role most sequencing labs need most of. In the middle is the scientist who adapts and troubleshoots analyses, chooses methods for new applications, and bridges the wet lab and the computation. At the more technical end is the engineer or developer who builds and maintains pipelines, manages the computational infrastructure, and creates new analytical capability.
Most labs conflate these into a single imagined hire, the bioinformatician who does everything, and then either cannot find or cannot afford that person, because someone who spans the full spectrum is rare and expensive. The more productive approach is to identify which part of the spectrum your lab actually needs. A lab running standard applications on validated pipelines needs the analyst end and can treat the engineering as an occasional external need; a lab pushing into novel methods needs the scientist or engineer end. Matching the role to the real need is the first staffing decision and the one that most affects both cost and fit.
Embedded, Shared, or Contracted
There are three fundamentally different ways to provide bioinformatics capability, and the right one depends on volume, budget, and how much control and continuity the lab needs. An embedded analyst is a dedicated member of your own team, giving the deepest integration, the fastest turnaround, and full alignment with your workflow, at the cost of a full salary and the responsibility to keep that person busy, current, and retained. Shared support from a core facility or institutional bioinformatics group spreads the cost across many users and gives access to broader expertise, at the cost of competing with other groups for that shared capacity and accepting the core’s priorities and turnaround. Contracted external bioinformatics converts the capability into a variable, per-project cost with no hiring commitment, which suits occasional or spiky needs, at the cost of less integration, less control, and dependence on an outside provider.
Model | Best Fit | The Tradeoff |
Embedded analyst | Steady, high volume needing fast turnaround and tight workflow integration | Full salary and the duty to keep the person busy, current, and retained |
Shared core support | Moderate or variable volume; access to broad expertise on a budget | Competing for shared capacity; the core’s priorities and turnaround govern |
Contracted external | Occasional, spiky, or specialized needs without a hiring commitment | Less integration and control; dependence on an outside provider |
Table 1. Three models for providing bioinformatics capability. The right choice follows from volume, budget, and how much integration, control, and continuity the lab needs, and many labs combine them.
Lab Management Certificate
The Lab Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
These are not mutually exclusive, and many labs combine them deliberately: an embedded analyst for routine production, shared or contracted support for specialized or overflow work. The decision mirrors the broader in-house-versus-outsource logic that runs through sequencing operations, and the same principle applies, match the model to the volume and the predictability of the need, rather than defaulting to hiring or to outsourcing on reflex.
Salary Ranges and Retention
Bioinformatics staff are expensive and in demand, and any salary figure has to come with its source and date because the published numbers vary dramatically, both because the roles differ and because the sources measure differently. As of 2026, base-salary data from salary.com, PayScale, and ZipRecruiter place a typical bioinformatician in the rough range of the mid-eighty to low-hundred-thousands, while Glassdoor’s figures, which blend in bonus and equity as total compensation, run substantially higher. Synthesizing across these sources, a workable planning picture for the United States in 2026 is roughly as follows, with the strong caveat that the sources disagree and local benchmarking is essential.
Career Stage | Rough US Range, 2026 | Notes |
Entry-level analyst | ~$75,000 to $100,000 | Titles like research associate or analyst; base salary |
Mid-level scientist | ~$100,000 to $150,000 | Several years of experience; the common working level |
Senior scientist | ~$150,000 to $220,000+ | Deep expertise; higher in top markets and total comp |
Director or principal | $250,000 to $300,000+ | Total compensation including bonus and equity |
Table 2. Rough US bioinformatics compensation ranges for 2026, synthesized from Glassdoor, salary.com, PayScale, ZipRecruiter, and compbiojobs (2026). Published sources disagree substantially and figures vary by geography, experience, and sector; treat these as a starting point and benchmark against your own market.
The Sources Disagree, So Do Not Trust One NumberFor the same role, published salary figures can differ by tens of thousands of dollars, because some report base salary and others report total compensation including bonus and equity, because samples differ, and because geography moves the number enormously, with major biotech hubs paying well above the national range. This is not a reason to distrust the data but a reason to use it correctly: treat any single figure as one data point, gather several sources, weight the ones that match your role definition and location, and benchmark against actual local postings. A salary decision made on one national average is likely to be wrong for your specific market in one direction or the other. |
Interested in lab leadership?
Retention matters as much as the salary, because bioinformatics skills are portable and in demand, so a good analyst has options. The most acute form of this risk is the single-analyst dependency: a lab whose entire analysis capability rests on one person loses that capability entirely when the person leaves, taking the operational knowledge with them. Mitigating that, through documentation, cross-training, or a support model that does not depend on one individual, is as important as setting the salary competitively, and it is the retention risk most specific to a small bioinformatics function.
Training Bench Staff vs. Hiring
A common and reasonable question is whether to train an existing, capable bench scientist to do the analysis rather than hiring a specialist, and the honest answer is that it depends on the depth and permanence of the need. For a lab running standard applications on established, validated pipelines, training a motivated bench scientist to run those pipelines and interpret the output can be both cheaper and effective, since the analytical work is bounded and repeatable and the person already understands the biology. Training resources and structured approaches for building that capability in existing staff are covered in Training Lab Staff on NGS Platforms: A Practical Playbook.
The approach has real limits that a sound decision respects. Training a bench scientist works for running established analyses; it does not manufacture the deeper expertise needed to develop new methods, troubleshoot hard failures, or build and validate pipelines. And it does not solve the delay problem if the trained scientist is still expected to do their bench job too, since the analysis will again compete for their time. Training is a real option for bounded, routine analysis on top of adequate time to do it; it is not a substitute for specialist capability when the work genuinely requires it, and mistaking one for the other is how a lab ends up with analysis that is both late and beyond the trained person’s depth.
Managing Analysis Backlog
An analysis backlog is the measurable symptom of understaffed bioinformatics, and it is more dangerous than a sample backlog precisely because it is quieter. When samples pile up before sequencing, the constraint is visible and everyone feels it. When completed runs pile up waiting for analysis, the money has already been spent, the instrument time is already consumed, and the only thing missing is the result, so the problem is easy to overlook until someone asks why data generated months ago has not produced an answer. The backlog is the delay from the hook made concrete: the cost of understaffed analysis, accumulating out of sight.
Preventing it means treating analysis capacity as something to be sized and scaled alongside sequencing capacity, not as an afterthought that will somehow keep up. A program that plans to double its sequencing output without planning the corresponding analysis capacity is planning a backlog. Monitoring the time from run completion to delivered result, and watching it for the upward drift that signals analysis falling behind, gives early warning before the backlog becomes a crisis. This is the specific form, for data analysis, of the principle that analysis capacity is the resource a growing sequencing program most often runs out of first, developed in Managing NGS Data: Storage, Compute, Retention, and Staffing. Staffing the analysis deliberately, in whatever model fits, is what keeps expensive sequencing capacity from producing data no one can turn into results. How this fits the whole program is in Next-Generation Sequencing in the Lab: A Manager’s Guide to Building, Budgeting, and Scaling NGS Capacity.
This article was produced under Lab Manager's AI Editorial Guidelines.
